Drug
S 588410
S 588410: highest development phase Phase 2, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| S-588410 NCT02410369 | Phase 2 | Non-small- Cell Lung Cancer |
Latest
No recent events.
Follow S 588410 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.